HUMAN MELANOMA CELLULAR LINE mel P USED IN PREPARING ANTITUMOR VACCINE

FIELD: biotechnology, medicine, oncology. ^ SUBSTANCE: invention relates to a novel human melanoma cellular line mel P possessing stable cultural and morphological indices that is stored in the Specialized collection of cellular cultures of Cytology institute RAS at number PKKK (P) 688D. The cellula...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MOROZOVA LIDIJA FEDOROVNA, LARIN SERGEJ SERGEEVICH, PALKINA TAT'JANA NIKOLAEVNA, MIKHAJLOVA IRINA NIKOLAEVNA, BARYSHNIKOV ANATOLIJ JUR'EVICH, BUROVA OL'GA SEMENOVNA, GEORGIEV GEORGIJ PAVLOVICH, VOROZHTSOV GEORGIJ NIKOLAEVICH, DEMIDOV LEV VADIMOVICH, KOZLOV ALEKSEJ MIKHAJLOVICH, GNUCHEV NIKOLAJ VASIL'EVICH
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: biotechnology, medicine, oncology. ^ SUBSTANCE: invention relates to a novel human melanoma cellular line mel P possessing stable cultural and morphological indices that is stored in the Specialized collection of cellular cultures of Cytology institute RAS at number PKKK (P) 688D. The cellular line is characterized by expression of melanoma (differentiating) markers - CD-63, HMB-45 and HMW and cancer-testicular marker MAGE-3. The line can be used in creature of antitumor (all-cellular, genetic engineering) vaccines used in treatment of melanoma and other malignant neoplasms. Using this cellular line provides preparing the novel effective antitumor vaccine. Invention can b used in medicine for vaccine therapy of malignant neoplasms. ^ EFFECT: valuable medicinal properties of cellular line. ^ 1 tbl, 2 ex